In line with the new strategic plan of Pharmacotherapy Publications, Inc. (PPI), the PPI Board of Directors and staff have been hard at work implementing and advancing PPI’s strategic priorities. One of our key focus areas is supporting scholars and enhancing PPI’s publications and services. Therefore, we are excited to share updates on recent PPI initiatives.

PPI participated in several activities at the recent ACCP Global Conference on Clinical Pharmacy in San Francisco, October 17–21, 2015.

• PPI and the ACCP Research Institute cohosted a joint open house that allowed ACCP members and meeting attendees to meet one on one or in a small group/roundtable format with members of our board of directors and scientific editorial council. This venue allowed attendees to receive tips on how to get more involved with Pharmacotherapy, the official journal of ACCP. Attendees had the opportunity to interact with editorial staff, receive information on how to develop manuscripts of interest to PPI, and learn how to become a Pharmacotherapy reviewer and editorial board member. In addition, we shared information with international attendees on how to become involved as an international author and reviewer for PPI.
• After the open house event, we hosted a scientific session focused on developing the skills of a scientific author. During this session, Pharmacotherapy Scientific Editors Stuart Haines and James Tisdale addressed issues important to emerging scholars and authors such as how to plan and prepare a paper for submission to a peer-reviewed journal, address authorship issues, review papers and abstracts, and respond to reviewer comments in developing a revised manuscript for resubmission.

We were impressed with the level of interest, positive feedback, and attendance at these sessions. If you were unable to attend and are interested in learning more about “Scientific Author Development,” the program is available online. We hope to see many members at future PPI events―for those who had the opportunity to participate this year, we hope you become more involved with PPI!

We also express our gratitude to Pharmacotherapy Editor-in-Chief Lindsay DeVane; Scientific Editors Vicki Ellingrod, Stuart Haines, and James Tisdale; and Board of Directors members William Miller and Terry Schwinghammer for their many contributions to these events.

Part of our efforts to increase Pharmacotherapy’s impact in the field of pharmacy have entailed revitalizing the editorial board. We are pleased to announce the addition of the following new editorial board members:

William L. Baker Jr, Pharm.D., FCCP, BCPS-AQ Cardiology
University of Connecticut School of Pharmacy

Jeffrey R. Bishop, Pharm.D., M.S., BCPP
University of Minnesota Department of Experimental and Clinical Pharmacology

Matthew J. Byerly, M.D.
Montana State University

Simon Jonathan Cheshire Davies
D.M. (Oxon), M.A. (Oxon), M.B.B.S. (Lond)., M.R.C.Psych.
M.Sc. (Maastricht/Florence), M.Sc. Epidemiol. (Lond).
University of Toronto, Canada

William L. Galanter, M.D., Ph.D., M.S.
University of Illinois College of Medicine

Candice L. Garwood, Pharm.D., FCCP, BCPS
Eugene Applebaum College of Pharmacy and Health Sciences

Donald Harvey, Pharm.D., FCCP, BCOP
Emory University School of Medicine

Brian R. Overholser, Pharm.D., FCCP
Purdue University

Steven M. Smith, Pharm.D., MPH, BCPS
University of Florida

Mary Ross Southworth, Pharm.D.
U.S. Food and Drug Administration

Kathleen A. Stringer, Pharm.D., FCCP
University of Michigan

Kristin W. Weitzel, Pharm.D., FAPhA
University of Florida College of Pharmacy

Daniel M. Witt, Pharm.D., FCCP, BCPS
University of Utah College of Pharmacy

We extend a warm welcome to all of our new editorial members and thank our current members for their continued support of Pharmacotherapy.

PPI is also working to increase its social media presence, and we are proud to announce the launch of our new Twitter account @PharmacoJournal. Please follow us to keep abreast of the latest PPI initiatives and cutting-edge science and practice publications released in Pharmacotherapy.